
Body horror has quietly become the most commercially viable corner of the genre again, which would have sounded unlikely even five years ago. The Substance earned an Oscar, Cronenberg’s influence is all over studio development slates, and the pharmaceutical-conspiracy angle in particular seems to be having a moment after Zach Cregger’s Resident Evil leaned hard into corporate medical dread.
So the timing feels right for an actor like Joel Kinnaman, who has spent much of his career playing men whose bodies get taken away from them, to headline one of these. Per The Hollywood Reporter, Kinnaman is set to star in The Cell, a creature thriller from Sleeping Dogs director Adam Cooper, with Highland Film Group launching worldwide sales at this week’s American Film Market in Los Angeles. The premise puts Kinnaman in Jeff Goldblum territory, broadly speaking. Per THR‘s logline:
“Kinnaman plays Ryan Weaver, an investigative journalist preparing to expose a powerful pharmaceutical company when he wakes up imprisoned inside a secret medical testing facility. Told he is dangerously ill, Ryan discovers that patients are being isolated, drugged, and subjected to disturbing experiments — and that his captors appear more interested in studying him than curing him. As his body begins to mutate, Ryan searches for an escape. But what he discovers in the facility’s lower levels suggests its operators are creating something far worse than the disease they claim to be treating.”
With Kinnaman’s character trapped inside a secret medical facility, fighting to escape as disturbing experiments begin mutating his body, The Cell sounds like Die Hard meets Resident Evil, combining a one-man survival thriller with a biological horror nightmare. The mutation hook is what separates this from the standard wrongful-confinement thriller, and arguably what makes the casting interesting. Kinnaman already played a man rebuilt against his will in the 2014 RoboCop remake and a consciousness shuffled between bodies in Altered Carbon, so a slow physical transformation is almost a thematic continuation for him. Cooper clearly sees the role as an endurance test, saying in a statement, “For a character that is in almost every frame of the film, it is a gift to have a lead actor as talented as Joel embody them, and I can’t wait to share this story with audiences.”
Cooper is a modest bet behind the camera, if an understandable one. His directing debut Sleeping Dogs put Russell Crowe through a memory-loss noir, and his screenwriting resume includes Assassin’s Creed and Allegiant, which won’t excite anyone but does suggest he knows how studio genre machinery works. The script comes from Evan Turner, who has a story credit on the viral-thread adaptation Dear David, and Ben Zazove. Highland CEO Arianne Fraser is selling the duality angle, saying:
“Joel Kinnaman shines as both the sharp investigative journalist closing in on the truth and the tortured and increasingly isolated man whose best chance of escape is to embrace the terrifying changes that have taken over his body.”
The announcement lands days after James Gunn and Peter Safran’s reported exit from DC Studios left Kinnaman’s Rick Flag Sr. future uncertain, which may make an AFM package with a February 2027 shoot date look like sensible scheduling. Independent creature features live or die on execution, but this one at least knows what it wants to be.
POLL
Question 1 of 3
